PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
42.82M
Worse than VKTX's estimated revenue of 430.93M.
-8.56M
Worse than VKTX's estimated ebitda of 0.
-0.59
Worse than VKTX's estimated eps of -0.34.
-17.89M
Better than VKTX's estimated net income of -32.35M.
-8.56M
Worse than VKTX's estimated ebit of 0.
1.59B
Worse than VKTX's estimated sg&a expense of 0.
Analyze DCF forecasts for the company and compare them with competitors.
81.00K
Better than VKTX's revenue of 0.00.
-92.14%
Worse than VKTX's revenue growth rate of 0.00%.
-51.13M
Better than VKTX's ebitda of -100.83M.
-63123.46%
Worse than VKTX's ebitda margin of 100.00%.
-51.92M
Better than VKTX's ebit of -100.83M.
-64098.77%
Worse than VKTX's ebit margin of 100.00%.
790.00K
Worse than VKTX's depreciation of 0.00.
76.68M
Worse than VKTX's total cash of 362.08M.
94662.96%
Better than VKTX's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
7.95M
Worse than VKTX's accounts payable of 7.51M.
9818.52%
Worse than VKTX's payables as percentage of revenue of 100.00%.
-153.00K
Better than VKTX's capital expenditure of 0.00.
-188.89%
Better than VKTX's capex as percentage of revenue of 100.00%.
4.99%
Better than VKTX's weighted average cost of capital (wacc) of 8.95%.
5.02%
Better than VKTX's cost of equity of 8.95%.
4.08%
Better than VKTX's cost of debt of 6.98%.
-0.23
Better than VKTX's beta of 0.99.
30.07M
Better than VKTX's diluted shares outstanding of 94.35M.
1.57M
Worse than VKTX's total debt of 1.26M.
49.31M
Worse than VKTX's total equity of 3.96B.
50.89M
Worse than VKTX's total capital of 3.96B.
3.09%
Worse than VKTX's debt weighting of 0.03%.
96.91%
Worse than VKTX's equity weighting of 99.97%.
-51.92M
Better than VKTX's ebiat of -100.83M.
-53.46M
Better than VKTX's unlevered free cash flow of -101.84M.
2.00%
Equal to VKTX's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than VKTX's net debt of -54.26M.
71.33M
Better than VKTX's equity value of 47.36M.
2.37
Better than VKTX's equity value per share of 0.50.